Univariable | Multivariable | |||
---|---|---|---|---|
Clinical factors | HR (95% CI) | P value | HR (95% CI) | P value |
Assessed age | 0.981 (0.951–1.012) | 0.225 | 0.975 (0.940–1.010) | 0.158 |
Gender | 0.437 (0.207–0.923) | 0.798 | * | * |
MDA5+ DM | 2.830 (1.067–7.505) | 0.037 | 3.254 (1.209–8.756) | 0.02 |
AAV | 0.674 (0.089, 5.099) | 0.702 | * | * |
SLE | 1.062 (0.346, 3.265) | 0.916 | * | * |
CD4+ T cell counts | 0.995 (0.989–1.001) | 0.083 | 0.994 (0.989–1.000) | 0.04 |
Lymphocyte counts | 0.142 (0.025–0.808) | 0.028 | * | * |
Interstitial lung disease | 1.537 (0.540–4.375) | 0.421 | * | * |
Steroid dose | 0.291 (0.063, 1.350) | 0.115 | * | * |
Cyclophosphamide | 1.807 (0.586, 5.568) | 0.303 | * | * |
Rituximab | 0.854 (0.113, 6.450) | 0.878 | * | * |
Time to anti-PJP treatment | 1.577 (0.607–4.099) | 0.35 | * | * |
Disease duration | 1.003 (0.988–1.018) | 0.677 | * | * |